It gives you one place to look, confirm your numbers, and move forward with confidence
Toosendanin induced hepatotoxicity via triggering PERK-eIF2alpha-ATF4 mediated ferroptosis
To cover the full injury course, both the acute and prolonged periods, the supporting evidence goes with the various time points (i.e., at 1 min, 15 min, 24 h or 48 h ligation-time) for the application of the BPC 157 therapy
TB-500 is a systemic recovery peptide: a synthetic fragment of Thymosin Beta-4, it circulates throughout the body to reduce inflammation, improve cell migration, and support recovery across multiple tissue types simultaneously
Ficlatuzimab is currently the only biological therapy undergoing trial that targets the c-MET/HGF axis in HNSCC